Quantitative measurement of HER2 expression in breast cancers: comparison with ‘real-world’ routine HER2 testing in a multicenter Collaborative Biomarker Study and correlation with overall survival-Reference-Cited by-同舟云学术

Quantitative measurement of HER2 expression in breast cancers: comparison with ‘real-world’ routine HER2 testing in a multicenter Collaborative Biomarker Study and correlation with overall survival

Published:2015-03-18 Issue:1 Volume:17 Page:
ISSN:1465-542X
Container-title:Breast Cancer Research
language:en
Short-container-title:Breast Cancer Res

Author:

Yardley Denise A,Kaufman Peter A,Huang Weidong,Krekow Lea,Savin Michael,Lawler William E,Zrada Stephen,Starr Alexander,Einhorn Harvey,Schwartzberg Lee S,Adams John W,Lie Yolanda,Paquet Agnes C,Sperinde Jeff,Haddad Mojgan,Anderson Steve,Brigino Marlon,Pesano Rick,Bates Michael P,Weidler Jodi,Bosserman Linda

Publisher

Springer Science and Business Media LLC

Link

http://link.springer.com/content/pdf/10.1186/s13058-015-0543-x.pdf

Reference25 articles.

1. Slamon DJ, Godolphin W, Jones LA, Holt JA, Wong SG, Keith DE, et al. Studies of the HER2/neu proto-oncogene in human breast and ovarian cancer. Science. 1989;244:707–12.

2. Yarden Y, Sliwkowski MX. Untangling the ErbB signaling network. Nat Rev Mol Cell Biol. 2001;2:127–37.

3. Slamon DJ, Clark GM, Wong SG, Levin WJ, Ullrich A, McGuire WL. Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene. Science. 1987;235:177–82.

4. Baselga J, Gelmon KA, Verma S, Wardley A, Conte P, Miles D, et al. Phase II trial of pertuzumab and trastuzumab in patients with human epidermal growth factor receptor 2-positive metastatic breast cancer that progressed during prior trastuzumab therapy. J Clin Oncol. 2010;28:1138–44.

5. Geyer CE, Forster J, Lindquist D, Chan S, Romieu CG, Pienkowski T, et al. Lapatinib plus capecitabine for HER2-positive advanced breast cancer. N Engl J Med. 2006;355:2733–43.

Cited by 36 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Dual HER2 inhibition: mechanisms of synergy, patient selection, and resistance;Nature Reviews Clinical Oncology;2024-09-13

2. Brain Radiotherapy Combined with Targeted Therapy for HER2-Positive Breast Cancer Patients with Brain Metastases;Breast Cancer: Targets and Therapy;2024-07

3. Novel approach to HER2 quantification using phosphor-integrated dots in human breast invasive cancer microarray;PLOS ONE;2024-05-15

4. Open questions, current challenges, and future perspectives in targeting human epidermal growth factor receptor 2-low breast cancer;ESMO Open;2024-04

5. Immunohistochemical assessment of HER2 low breast cancer: interobserver reproducibility and correlation with digital image analysis;Breast Cancer Research and Treatment;2024-03-05